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Abstract
The increased affordability of whole genome sequencing has motivated its use for phenotypic stud-
ies. We address the problem of learning interpretable models for discrete phenotypes from whole
genomes. We propose a general approach that relies on the Set Covering Machine and a k-mer rep-
resentation of the genomes. We show results for the problem of predicting the resistance of Pseu-
domonas aeruginosa, an important human pathogen, against 4 antibiotics. Our results demonstrate
that extremely sparse models which are biologically relevant can be learnt using this approach.
1 Introduction
Recent advances in next-generation sequencing (NGS) have led to a tremendous increase in the affordability of whole
genome sequencing (WGS) [5]. The reduced cost and increased throughput of NGS have motivated the use of WGS
for phenotypic study [5, 6, 8, 15]. Particularly, it is now possible to use whole genome sequences, instead of DNA
microarrays, which require prior knowledge of the genomic regions of interest. Learning models which can accurately
predict a discrete phenotype from a genome has direct applications in the clinical setting and can lead to a better
understanding of biological processes. This is especially true if the learnt model is simple and easy to interpret, which,
unfortunately, is not the case of most learning algorithms. Moreover, the large size and increased availability of WGS
data give rise to new computational challenges which must be addressed.
Machine learning algorithms require that the genomes be represented by a set of features. One common representation
consists in a set of single nucleotide polymorphisms (SNP) [3]. Obtaining the SNPs for multiple genomes requires
multiple sequence alignment, which is computationally expensive and affected by genome rearrangements [9]. More-
over, potentially important information about the genome can be lost in this process. In this paper we will favor an
alternative approach, inspired from the “bag-of-words” model that is heavily used in the domain of text classification.
It consists in representing each genome by the presence or absence of k-mers, which are words of k nucleotides that
are possibly its subsequences [6]. In addition, this approach does not require any sequence alignement [9].
As previously stated, another key requirement when learning to predict a phenotype is that the model must be inter-
pretable by domain experts. Interpretable models provide biological insight on the decision function and can lead
to the discovery of novel biological processes. Models must thus be sparse and composed of elements from which
sufficient biological knowledge can be extracted. Sparsity of the model is desirable since it contributes to reducing the
cost of validation and promotes its usage in a clinical setting. Many state-of-the-art learning algorithms do not provide
interpretable models. This is the case of the Support Vector Machine (SVM) [4], which yields dense models. The
Lasso [14] yields sparse models compared to the SVM. Nevertheless, they often contain a large number of non-null
coefficients, rendering their biological understanding difficult.
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In this paper, we propose a novel approach for learning sparse and interpretable models from whole genomes for
predicting discrete phenotypes. Our approach relies on the Set Covering Machine [11], a learning algorithm that
produces highly sparse models that achieved state-of-the-art accuracy for many learning task, such as learning from
DNA microarray data [12]. The models obtained are short conjunctions or disjunctions of boolean valued rules which
can explicitly highlight the importance of specific DNA sequences.
We first present the Set Covering Machine learning algorithm. Subsequently, we demonstrate how it can be applied to
predict phenotypes based on whole genomes. We then present an example application to the problem of predicting the
antimicrobial resistance of Pseudomonas aeruginosa (PA), an opportunistic, nosocomial pathogen of immunocom-
promised individuals [7]. PA typically infects the pulmonary tract, urinary tract, burns, wounds, and also causes other
blood infections. It is an important human pathogen. Finally, we discuss the models found for the resistance of PA
against four antibiotics, the limitations of the approach, and propose paths to extend our work.
2 Methods
2.1 The Set Covering Machine
In the supervised machine learning setting, we assume that data are available as a set S = {(xi, yi)}mi=1 ∼ Dm, where
xi ∈ X is a training example, yi ∈ Y its associated label and D is a data generating distribution. We consider binary
classification problems where Y = {0, 1}. The goal of a learning algorithm is to obtain a predictor h : X → Y , such
that h(x) = y for most (x, y) ∼ D. The Set Covering Machine (SCM) [11] is a learning algorithm that produces
predictors that are conjunctions or disjunctions of boolean valued rules ri : X → {0, 1}. Given a set of rules, the
SCM attempts to find the smallest subset of rules that correctly classifies the data. As mentioned in [11], this problem
can be reduced to the set cover problem which is known to be NP-hard. However, the SCM uses a greedy algorithm
to obtain an approximate solution with a worst case guarantee. Algorithm 1 presents the SCM algorithm in the case
where the returned predictor is a conjunction of boolean valued rules. The disjunction case can be obtained from the
previous one by using S ′ = {(xi,¬yi) : (xi, yi) ∈ S} as the set of training examples for Algorithm 1 and taking the
complement of the returned predictor h. This follows from the De Morgan law: ¬∧r?i ∈R? r?i (x) = ∨r?i ∈R? ¬r?i (x).
In Algorithm 1, the parameter s acts as a regularizer by limiting the complexity of h. The parameter p adds robustness
to noise and to class imbalance, by controlling a trade-off between minimizing the error on each class. If more than
one rule have a maximal utility value Ui, we select the one which most reduces the empirical risk and thus maximises
|Ai| − |Bi|. If there still exists a tie, we select either of the rules. Notice that, at each iteration, only the examples
for which the outcome of h is not already determined are considered. This prevents the selection of correlated rules,
which would unnecessarily increase the complexity of the predictor. This is crucial in a clinical setting, since increased
predictor complexity can lead to dispensable costs.
The running time complexity of Algorithm 1 isO(|R|· |S| ·s) in the worst case. It thus scales linearly in the number of
rules and the number of training examples. In addition, note that at each iteration, the computation can be parallelized
by distributing the computation of the |Ai| and |Bi| on multiple cores.
2.2 Applying the Set Covering Machine to whole genomes
In order to apply the SCM to whole genomes, we use a k-mer representation. First, given a dataset S = {(xi, yi)}mi=1,
where xi is a genome and yi ∈ {0, 1} is the phenotype, we define K as the set of all unique k-mers that are at least
in one genome. All overlapping k-mers are considered while constructing this set. Note that k-mers that are in all
genomes can be discarded, since they cannot be selected by Algorithm 1. Then, for each (x, y) ∈ S , we represent
a genome x by φ(x), a boolean vector of |K| dimensions where component φi(x) = 1 if ki ∈ K is in genome
x and 0 otherwise. Then, for each k-mer ki ∈ K, we define a presence rule pki(φ(x)) def= I(φi(x) = 1) and an
absence rule aki(φ(x))
def
= I(φi(x)=0), where I is the indicator function. We can then apply Algorithm 1 by taking
S ′ = {(φ(xi), yi) : (xi, yi) ∈ S} as the training set of examples and by using the set of 2 · |K| presence and absence
rules forR. By doing so, we obtain a predictor which explicitly highlights the importance of a small set of k-mers for
predicting a phenotype. This predictor has a form which is simple to interpret, since its predictions are the outcome of
a simple logical operation. The running time complexity of using Algorithm 1 in this setting is O(|K| · |S| · s).
2.3 Predicting the antimicrobial resistance of Pseudomonas aeruginosa
We validated our approach by addressing the problem of antibiotic resistance. There is a pressing need for rapid clin-
ical diagnostic tests, that can accurately predict the resistance of a bacterial strain to a wide range of antibiotics [16].
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Algorithm 1: Train SCM(S,R, p, s)
input: S: A set of training examples,R: A set of boolean valued rules, p: The class tradeoff parameter, s: The
maximum number of rules in h.
R? ← ∅
P ← the set of examples in S with label 1
N ← the set of examples in S with label 0
stop← False
while N 6= ∅ and |R?| < s and ¬stop do
∀ri ∈ R, Ai ← the subset of N correctly classified by ri
∀ri ∈ R, Bi ← the subset of P misclassified by ri
∀ri ∈ R, Ui ← |Ai| − p · |Bi| if |Ai| ≥ |Bi| and −∞ otherwise
i? ← argmax
i
Ui
if Ui? 6= −∞ then
R? ← R? ∪ {ri?}
N ← N −Ai?
P ← P − Bi?
else
stop = True
end
end
return h, where h(x) =
∧
r?i ∈R? r
?
i (x)
Antibiotic Resistant Sensitive Total 2 · |K|
Amikacin 84 281 365 119 023 612
Doripenem 137 226 363 118 580 512
Levofloxacin 169 189 358 118 335 666
Meropenem 153 215 368 118 931 911
Table 1: Number of resistant/sensitive strains and boolean valued rules (2 · |K|) for each antibiotic
Our approach could be used to obtain interpretable predictors of the resistant phenotype for multiple antibiotics. In
addition to assist in a clinical setting, these may help to uncover new resistance mechanisms and ultimately identify
new drug targets. In order to learn such models, we used a dataset containing the genomes of 390 Pseudomonas
aeruginosa strains and their measured resistance phenotype (resistant, intermediate or sensitive) for 4 antibiotics [7].
We addressed each antibiotic as a distinct classification problem. We binarized each problem by discarding inter-
mediate strains and assigning the 1 label to resistant strains and the 0 label to sensitive strains. For constructing the
k-mer set K, we used k = 31, because it is a standard parameter used in de novo genome assembly algorithms [2]; if
k = 31 provides enough information to allow good genome assembly, it should be suitable for our learning task. An
overview of the resulting dataset is shown in Table 1.
For each antibiotic, we obtained sets K which contained millions of k-mers. Therefore, the dimensionality of φ(x)
was extremely high, leading to the problem of storing the examples in memory. In order to overcome this problem, we
stored the φ(x) vectors on disk in an HDF5 dataset [13], which supports built-in compression and array-like access to
the data. At each iteration of Algorithm 1, we accessed the data by blocks of a fixed number of rows and columns. This
led to an implementation for which the memory usage was fully controllable. For each antibiotic, the first iteration of
Algorithm 1 took less than 7 minutes, while using a single CPU and 3 GB of RAM on a system equipped with a 2.8
GHz Intel Core i7 and a 5200 RPM hard drive. All subsequent iterations took less time.
3 Results and discussion
3.1 Evaluating the performance of the proposed approach
For each antibiotic, we conducted nested 5-fold cross-validation (CV). We first split the dataset into 5 parts, called the
outer-folds. One outer-fold was left out as a validation set to compute the risk of the algorithm, while the remaining
outer-folds formed a training dataset used to train the algorithm. On this inner dataset, we performed standard 5-fold
CV to select the algorithm’s hyperparameters. After choosing those minimizing the inner CV risk, we retrained the
algorithm using the whole inner dataset, and computed predictions for the examples of the left out outer-fold. We
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Antibiotic SCM SVM Majority
Risk |R?| Risk Risk
Amikacin 0.170 ± 0.024 3.0 ± 0.9 0.189 ± 0.032 0.230 ± 0.036
Doripenem 0.283 ± 0.046 1.4 ± 0.5 0.270 ± 0.012 0.378 ± 0.040
Levofloxacin 0.075 ± 0.025 1.6 ± 0.5 0.232 ± 0.029 0.472 ± 0.034
Meropenem 0.288 ± 0.018 1.0 ± 0.0 0.340 ± 0.043 0.416 ± 0.048
Table 2: All values presented in this table are means over the 5 outer-folds followed by their standard deviation. Hence,
risks for the SCM, the SVM and the majority class predictor are given for each antibiotic. For the SCM, we also show
the number of rules |R?| used. The best risk values are in bold.
repeated this procedure 5 times (once per outer fold) and reported the mean left out outer-fold risk, which corresponds
to an estimate of the risk incurred on novel data.
We conducted this experiment for our approach and selected hyperparameters p and s of Algorithm 1 from ranges
[10−1, 101] and {1, ..., 10} respectively. For comparison, we repeated the experiment using a SVM with a linear
kernel and selected the values of hyperparameter C in range [10−5, 109]. † In addition, in order to validate that our
approach actually learns from the WGS data, we compared to a predictor that predicts the majority class for each
antibiotic. The results are summarized in Table 2. On all but one antibiotic, our approach outperforms the SVM. This
is an interesting result, since our predictors are composed of very few rules, whereas the SVM decision function is
fully dense and thus attributes non-null weights to millions of rules. Moreover, these results confirm that our approach
indeed learns from the WGS data, since it outperforms the majority class predictor.
3.2 Biological relevance of the predictors
To evaluate the ability of our approach to learn biologically relevant models, we relearned an SCM on the entire dataset
of each antibiotic. The optimal parameters for each dataset were selected by 5-fold CV based on the same ranges as
in the previous experiment. For amikacin and meropenem, the obtained predictors are conjunctions of 5 and 2 rules
respectively. For doripenem and levofloxacin, the predictors are disjunctions of 2 rules. Hence, in each case, the
obtained predictor is based on a very small number of rules.
The predictor for levofloxacin is a disjunction of 2 absence rules for k-mers located in the wildtype DNA gyrase,
which is the target of levofloxacin. Interestingly, the first k-mer is located in the quinolone-resistance-determining
region of subunit A and covers two amino acids, Thr-83 and Asp-87, known to confer resistance to levofloxacin when
mutated [1]. Similarly, the second k-mer is located in subunit B and covers amino acids Ser-468 and Glu-470, which
also confer resistance when mutated [1]. Therefore, in this case, the predictor has recovered known biological facts.
For all other antibiotics, the model contains a rule relative to the absence of a k-mer in the DNA gyrase. However,
none of these antibiotics actually target the DNA gyrase.
In Figure 1, we see that most strains are resistant to multiple antibiotics and that many are resistant to all of them
(central set). Following this observation, we used each predictor to predict the labels of the training examples. We
analysed the distribution of false negatives among the sets of Figure 1 and found that only a slight fraction fall in
the central set. This suggests that, since the SCM can only learn one conjunction or disjunction, it learns the one
which best classifies the largest set of the training examples. The presence of the DNA gyrase in all the predictors can
be explained by a shared resistance with levofloxacin for many examples. In addition, this observation supports the
difference in the accuracies observed for levofloxacin and all other antibiotics in Table 2.
4 Conclusion
We have addressed the problem of learning interpretable models of phenotypes from whole genome sequences. We
have demonstrated that the Set Covering Machine can be used to achieve this goal. Our results for the problem
of predicting the antibiotic resistance of Pseudomonas aeruginosa suggest that our approach indeed yields sparse
and interpretable models. For one antibiotic, we have recovered the target gene and for the others, the models were
interpretable enough to gain insight on a limitation of our approach. Future works will therefore address the problem of
learning more than one conjunction/disjunction with the SCM. A disjunction of conjunctions can still be very sparse,
and may allow to model richer biological pathways than a single conjunction or a single disjunction.
†Note that learning with the SVM from the φ(x) vectors is equivalent to using the spectrum kernel [10].
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Figure 1: Distribution of the resistant strains among the antibiotics in the dataset.
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